Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Access Denied

    Difference Between HIV Rapid Test and Lab Test

    4 Takeaways From The 2026 NFL Schedule Release

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $1.63 Million
    Health

    WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $1.63 Million

    AdminBy AdminNo Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    JERSEY CITY, N.J., Oct. 2, 2025 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, has entered into warrant exercise agreements with three existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 812,775 of the Company’s shares of common stock (the “Existing Warrants”). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of approximately $1.63 million, the exercising holders will receive in a private placement new unregistered warrants (the “New Warrants”) to purchase up to an aggregate of 812,775 shares of common stock (equal to 100% of the shares of common stock issued in connection with the exercise of the Existing Warrants) with an exercise price of $3.00 per share.  The New Warrants are initially exercisable on the date that stockholder approval of the exercise of the New Warrants is obtained and will expire five years from the date of such approval. In connection with the exercise of the Existing Warrants, the Company agreed to reduce the exercise price of the Existing Warrants from $20.92 to $2.00 per share. The exercise of the Existing Warrants and the issuance of the New Warrants are expected to occur on October 2, 2025.

    The closing of the offering is expected to occur on or about October 2, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the warrant inducement are expected to be approximately $1.63 million, excluding any proceeds that may be received upon the exercise of the  New Warrants and before deducting placement agent fees and other offering expenses payable by the Company.

    WallachBeth Capital is acting as sole placement agent for the warrant inducement transaction.

    This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

    About WallachBeth Capital LLC

    WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community, connecting corporate clients with leading institutions, creating value for both issuers and investors. The firm’s experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions and ATM’s.

    Forward-Looking Statements and Safe Harbor Notice :

    This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which Healthcare Triangle, Inc. operates, as well as management’s beliefs and assumptions. Forward-looking statements include, but are not limited to, statements regarding revenue growth, margin expansion, market opportunities, and strategic initiatives. These statements involve risks, uncertainties, and assumptions that are difficult to predict. Actual outcomes may differ materially from those expressed or implied in any forward-looking statements due to various factors beyond the company’s control, including changes in market conditions, client demand, regulatory developments, and execution risks. Readers are cautioned not to place undue reliance on these forward-looking statements. Healthcare Triangle, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    SOURCE WallachBeth Capital LLC

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Difference Between HIV Rapid Test and Lab Test

    A Complete Guide to Mesothelioma: Causes, Symptoms, Treatment

    RHR: Revisiting the Gut-Immune Axis

    Kardea Brown on Love, Diabetes, and Reimagining Tradition

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Electrical fire to keep theater that hosts ‘The Book of Mormon’ closed through May 17

    The 2026 Grammy Award nominations are about be announced. Here’s what to know

    Disease of 1,000 faces shows how science is tackling immunity’s dark side

    Judge reverses Trump administration’s cuts of billions of dollars to Harvard University

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2026 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.